Research and Markets: This Global Research Report in Medicine and Biology Nanoscience and Nanotechnology is Now Available

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ce137e/nanotechnology_w) has announced the addition of the "Nanotechnology - World R&D Report 2008 - Research in Medicine and Biology Nanoscience and Nanotechnology" report to their offering.

This bibliometric report examines scientific activity in nanoscience using scientific papers, as well as intellectual property in nanotechnology using patents granted by the USPTO. The central aim of the scientometric and technometric analyses is to identify areas in which high-output, high-intensity, and high-impact research is being conducted. For this purpose, emphasis is placed on ranking research at the country, company and university levels. In addition, the report examines how nanoscale research and technology are evolving over time and features detailed analyses of eight non-mutually exclusive domains of nanoscale R&D.

Key findings include:

- The scientific output in nanoscience increased at a compound annual growth rate of nearly 16% during the last decade.

- The scientific output in Republic of Korea and China exhibit spectacular growth.

- The number of patents granted has also grown rapidly (10%).

- Nanomaterials, nanophotonics, nanoelectronics and nanoscience in medicine & biology represent the largest concentration of R&D.

- Growth is particularly fast in emerging domains, namely NEMS, energy and environment.

The Nanotechnology World R&D Report 2008 will help analysts and decision-makers to:

- Identify industry leaders in eight domains of nanoscience and nanotechnology

- Identify innovators and competitors, and estimate industry R&D capacity

- Find commercialization and scaling-up partners

- Gather competitive intelligence on S&T activities

- Find collaboration partners

- Identify takeover targets

- Identify where the best researchers are

- Identify and prioritize investment opportunities

- Identify the best locations to expand R&D facilities

- Compare an IP position with that of a competitor

- Anticipate threats to existing nanotechnology activities

- Gain insight into national dynamics and trends in emerging nanotechnologies

Key Topics Covered:

- Scientometric Analysis of Nanoscience, 1996-2006

-- Medicine and Biology Nanoscience

- Technometric Analysis of Nanotechnology, 1981-2006

-- Medicine and Biology Nanotechnology

Some of the Companies Mentioned:

- 3M

- Abbott Laboratories

- Affymetrix

- Agilent

- Akzona

- Alcatel-Lucent

- Amgen

- AstraZeneca

- BASF

- Battelle

- Bayer

- BioForce Nanosciences

- Bristol-Myers Squibb

- Dow Chemical

- Dow Corning

- DuPont

- Eastman Kodak

- Elan

- Eli Lilly and Company

- Forschungs. Jülich

- GE

- Genentech

- GlaxcoSmithKline

For more information visit http://www.researchandmarkets.com/research/ce137e/nanotechnology_w